Skip to main content
. 2022 Jan 24;11:790912. doi: 10.3389/fonc.2021.790912

Figure 4.

Figure 4

Genetic alterations in FBXO22 in different cancer types. (A) The distribution of different types of mutation in FBXO22 displayed using the COSMIC tool. (B) Potential correlation between FBXO22 alteration status and overall, progression-free, disease-free, and disease-specific survival in UCEC, as analyzed using the cBioPortal tool. (C) MDM2, PHLPP1, and PTEN expression in samples with wild-type or mutated FBXO22 in LUAD; CDKN1A, KDM4B, STK11, and PTEN expression in samples with wild-type or mutated FBXO22 in UCEC.